$Rezolve AI(RZLV)$ Brinks is probably wishing he had held onto AMD. He went long AMD back in 2014 and 2016 at roughly a $3 average cost, and eventually sold in the $200 range. He also made around 50% on his $Esperion Therapeutics(ESPR)$ position.
I know he has started a position in RZLV as well, which he has shown on his Twitter account.
Canyon got a group of us looking at RZLV after the $Alphabet(GOOG)$ Google partnership news and the subsequent earnings drop. The more I dig into it, the more compelling the valuation looks.
RZLV is arguably one of the most undervalued AI stocks out there. The company is growing revenue at an incredible rate, with H1 2026 revenue reaching $130.8M, up nearly 21x year over year, while FY2026 revenue guidance remains around $360M.
Then you have Google selecting RZLV's proprietary distributed database technology for deployment within Google Cloud, which gives the infrastructure side of the business significant validation.
At around $2.27 and roughly 2x forward sales, RZLV is a bargain.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
